{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:04:26Z","timestamp":1790787866583,"version":"4.1.0"},"reference-count":257,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00286","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T00:27:20Z","timestamp":1496017640000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":220,"title":["Discovery and Development of Calcium Channel Blockers"],"prefix":"10.3389","volume":"8","author":[{"given":"Th\u00e9ophile","family":"Godfraind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"Abernethy","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2125.1992.tb04125.x","article-title":"Drugs acting on calcium channels: potential treatment for ischaemic stroke","volume":"34","author":"Alps","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1211\/0022357991772844","article-title":"Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues","volume":"51","author":"Angelico","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00004647-199905000-00006","article-title":"Functional reduction and associated cellular rearrangement in SHRSP rat basilar arteries are affected by salt load and calcium antagonist treatment","volume":"19","author":"Arribas","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"B6","volume-title":"Hypertension, Antihypertensive Treatment and Cerebrovascular Disease","author":"Atkinson","year":"1990"},{"key":"B7","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/ana.20778","article-title":"Suppression of cortical spreading depression in migraine prophylaxis","volume":"59","author":"Ayata","year":"2006","journal-title":"Ann. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/00005344-199410000-00013","article-title":"Effect of nisoldipine on contractions evoked by endothelin-1 in human isolated distal and proximal coronary arteries and veins","volume":"24","author":"Balligand","year":"1994","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1073\/pnas.90.1.347","article-title":"Control of cardiac muscle cell function by an endogenous nitric oxide signaling system","volume":"90","author":"Balligand","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer's disease prevalence","volume":"10","author":"Barnes","year":"2011","journal-title":"Lancet Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/00005344-200111002-00007","article-title":"Endothelium and atherogenesis: endothelial therapy revisited","volume":"38","author":"Barton","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"14367","DOI":"10.1073\/pnas.95.24.14367","article-title":"Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice","volume":"95","author":"Barton","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1073\/pnas.81.20.6388","article-title":"Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state","volume":"81","author":"Bean","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/01.RES.59.2.229","article-title":"Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs","volume":"59","author":"Bean","year":"1986","journal-title":"Circ. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1097\/00005344-199118101-00006","article-title":"Low-dose felodipine treatment attenuates endothelial dysfunction in rabbits fed an atherogenic diet","volume":"18","author":"Becker","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B16","first-page":"386","article-title":"Selective block of myocardial T-type calcium channels by mibefradil: a comparison with the 1,4-dihydropyridine amlodipine","volume-title":"Low-Voltage-Activated T-type Ca Channels","author":"B\u00e9nardeau","year":"1998"},{"key":"B17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00004872-199102000-00004","article-title":"Protective effects of antihypertensive treatment with isradipine on the consequences of cerebral ischaemia in the spontaneously hypertensive rat","volume":"9","author":"Bentahila","year":"1991","journal-title":"J. Hypertens."},{"key":"B18","volume-title":"Calcium Antagonists and the Coronary Circulation","author":"Berdeaux","year":"1990"},{"key":"B19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0008-6363(99)00038-3","article-title":"Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release","volume":"42","author":"Bers","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nm0202-136","article-title":"Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model","volume":"8","author":"Bolay","year":"2002","journal-title":"Nat. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/00005344-198407000-00025","article-title":"Acute systemic and regional hemodynamic effects of felodipine, a new calcium antagonist, in conscious renal hypertensive rabbits","volume":"6","author":"Bolt","year":"1984","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1161\/01.ATV.17.11.2333","article-title":"Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice","volume":"17","author":"Bonthu","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jama.1996.03540100029024","article-title":"Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial","volume":"276","author":"Borhani","year":"1996","journal-title":"JAMA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/ana.1293","article-title":"Magnetoencephalographic fields from patients with spontaneous and induced migraine aura","volume":"50","author":"Bowyer","year":"2001","journal-title":"Ann. Neurol."},{"key":"B25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/978-3-642-70499-4_29","article-title":"Calcium antagonists for identification of mechanisms and treatment of patients with essential hypertension","volume-title":"Cardiovascular Effects of Dihydropyridine-Type Calcium Antagonists and Agonists","author":"B\u00fchler","year":"1985"},{"key":"B26","first-page":"110","article-title":"Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors","volume":"9","author":"Burges","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"B28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0002-9149(90)90732-G","article-title":"Beneficial and detrimental effects of lidoflazine in microvascular angina","volume":"66","author":"Cannon","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"a003947","DOI":"10.1101\/cshperspect.a003947","article-title":"Voltage-gated calcium channels","volume":"3","author":"Catterall","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B30","volume-title":"The IUPHAR Compendium of Voltage-Gated Ion Channels","author":"Catterall","year":"2002"},{"key":"B31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/pr.57.4.5","article-title":"International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1097\/00005344-198507004-00002","article-title":"Different Ca2+ channels along the arterial tree","volume":"7","author":"Cauvin","year":"1985","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ana.10158","article-title":"Cortical spreading depression and gene regulation: relevance to migraine","volume":"51","author":"Choudhuri","year":"2002","journal-title":"Ann. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/0306-3623(90)90439-S","article-title":"Action of pinaverium bromide, a calcium-antagonist, on gastrointestinal motility disorders","volume":"21","author":"Christen","year":"1990","journal-title":"Gen. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/qjmed\/hcg123","article-title":"The ALLHAT study: results and clinical implications","volume":"96","author":"Chrysant","year":"2003","journal-title":"QJM"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke"},{"key":"B37","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/00129492-200211000-00020","article-title":"Objective evaluation of the effect of flunarizine on vestibular neuritis","volume":"23","author":"Corvera","year":"2002","journal-title":"Otol. Neurotol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/0002-9343(81)90238-2","article-title":"Nifedipine and propranolol: a beneficial drug interaction","volume":"71","author":"Dargie","year":"1981","journal-title":"Am. J. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1043661802002360","article-title":"Selectivity of different calcium antagonists on T- and L-Type calcium currents in guinea-pig ventricular myocytes","volume":"46","author":"De Paoli","year":"2002","journal-title":"Pharmacol. Res."},{"key":"B41","first-page":"148","article-title":"Acute and chronic effect of verapamil in exercise-induced angina","volume-title":"Calcium Antagonism in Cardiovascular Therapy: Experience with Verapamil","author":"de Ponti","year":"1981"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0195-668X(03)00311-7","article-title":"VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study)","volume":"24","author":"De Simone","year":"2003","journal-title":"Eur. Heart J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1161\/hc3601.095927","article-title":"Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial","volume":"104","author":"Devereux","year":"2001","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.bbamem.2012.11.019","article-title":"The \u03b12\u03b4 subunits of voltage-gated calcium channels","volume":"1828","author":"Dolphin","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"B45","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1046\/j.1526-4610.2003.03091.x","article-title":"Normalization of high interictal cerebrovascular reactivity in migraine without aura by treatment with flunarizine","volume":"43","author":"Dora","year":"2003","journal-title":"Headache"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1161\/01.ATV.21.6.1017","article-title":"Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice","volume":"21","author":"d'Uscio","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1113\/jphysiol.1962.sp006897","article-title":"The need for calcium in the contractile responses induced by acetylcholine and potassium in the rat uterus","volume":"161","author":"Edman","year":"1962","journal-title":"J. Physiol."},{"key":"B48","first-page":"64","article-title":"Verapamil distribution in health and the diseased state","volume-title":"Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders","author":"Eichelbaum","year":"1983"},{"key":"B49","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0896-6273(00)81057-0","article-title":"Nomenclature of voltage-gated calcium channels","volume":"25","author":"Ertel","year":"2000","journal-title":"Neuron"},{"key":"B50","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3109\/10641963.2016.1174249","article-title":"Amlodipine treatment of hypertension associates with a decreased dementia risk","volume":"38","author":"Feldman","year":"2016","journal-title":"Clin. Exp. Hypertens."},{"key":"B51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF00373906","article-title":"Regulation of the L-type calcium channel alpha-1 subunit by chronic depolarization in the neuron-like PC12 and aortic smooth muscle A7r5 cell lines","volume":"430","author":"Feron","year":"1995","journal-title":"Pflugers Arch."},{"key":"B52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1432-1033.1994.tb18857.x","article-title":"Quantification of two splicing events in the L-type calcium channel alpha-1 subunit of intestinal smooth muscle and other tissues","volume":"222","author":"Feron","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1161\/CIR.0b013e318277d6a0","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/hrt.57.4.336","article-title":"A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris","volume":"57","author":"Findlay","year":"1987","journal-title":"Br. Heart J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0022-2828(87)80008-1","article-title":"Model experiments on anticalcinotic and antiarteriosclerotic arterial protection with calcium antagonists","volume":"19","author":"Fleckenstein","year":"1987","journal-title":"J. Mol. Cell Cardiol."},{"key":"B56","first-page":"R25","article-title":"A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium","volume":"307","author":"Fleckenstein","year":"1969","journal-title":"Pflugers Arch."},{"key":"B57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2165\/00003495-199200441-00005","article-title":"Calcium overload\u2013an important cellular mechanism in hypertension and arteriosclerosis","volume":"44","author":"Fleckenstein-Grun","year":"1992","journal-title":"Drugs"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study","volume":"162","author":"Forette","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00280110","article-title":"Nimodipine in migraine: clinical efficacy and endocrinological effects","volume":"41","author":"Formisano","year":"1991","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B60","first-page":"I51","article-title":"Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail","volume":"65","author":"Frishman","year":"1982","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-4-431-68048-2_18","article-title":"Hemodynamic effects of diltiazem in the spontaneously hypertensive rat and in human hypertension","volume-title":"Essential Hypertension; Calcium Mechanisms and Treatment","author":"Frohlich","year":"1986"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","article-title":"Nifedipine. Dose-related increase in mortality in patients with coronary heart disease","volume":"92","author":"Furberg","year":"1995","journal-title":"Circulation"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/sj.bjp.0701226","article-title":"Voltage and pH dependent block of cloned N-type Ca2+ channels by amlodipine","volume":"121","author":"Furukawa","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jacc.2013.11.007","article-title":"An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention","volume":"63","author":"Go","year":"2014","journal-title":"J. Am. Coll. Cardiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1113\/jphysiol.1976.sp011501","article-title":"Calcium exchange in vascular smooth muscle, action of noradrenaline and lanthanum","volume":"260","author":"Godfraind","year":"1976","journal-title":"J. Physiol."},{"key":"B66","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0022-3565(25)33494-4","article-title":"Actions of nifedipine on calcium fluxes and contraction in isolated rat arteries","volume":"224","author":"Godfraind","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B67","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-0773.1986.tb02518.x","article-title":"Calcium entry blockade and excitation contraction coupling in the cardiovascular system (with an attempt of pharmacological classification)","volume":"58","author":"Godfraind","year":"1986","journal-title":"Acta Pharmacol. Toxicol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0163-7258(94)90033-7","article-title":"Calcium antagonists and vasodilatation","volume":"64","author":"Godfraind","year":"1994","journal-title":"Pharmacol. Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1097\/00005344-200000001-00006","article-title":"New insights into the therapeutic mechanism of action of calcium channel blockers in salt-dependent hypertension: their interaction with endothelin gene expression","volume":"35","author":"Godfraind","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B70","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-0348-7859-3","volume-title":"Calcium Channel Blockers","author":"Godfraind","year":"2004"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1098\/rstb.2005.1774","article-title":"Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis","volume":"360","author":"Godfraind","year":"2005","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1074248414530508","article-title":"Calcium channel blockers in cardiovascular pharmacotherapy","volume":"19","author":"Godfraind","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"B73","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0022-3565(25)32562-0","article-title":"The inhibition by flunarizine of the norepinephrine-evoked contraction and calcium influx in rat aorta and mesenteric arteries","volume":"217","author":"Godfraind","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1476-5381.1969.tb08010.x","article-title":"Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle","volume":"36","author":"Godfraind","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B75","first-page":"P354","article-title":"Inhibition by cinnarizine and chlorpromazine of the contraction induced by calcium and adrenaline in vascular smooth muscle","volume":"35","author":"Godfraind","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B76","first-page":"1209","article-title":"Comparative study of drugs inhibiting the contractile response of isolated vessels of human and animal origin","volume":"23","author":"Godfraind","year":"1968","journal-title":"Therapie"},{"key":"B77","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/BF00051108","article-title":"Calcium antagonists and endothelial function: focus on nitric oxide and endothelin","volume":"10","author":"Godfraind","year":"1996","journal-title":"Cardiovasc. Drugs Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fphar.2015.00010","article-title":"Ambiguities in dietary antioxidant supplementation compared to calcium channel blockers therapy","volume":"6","author":"Godfraind","year":"2015","journal-title":"Front. Pharmacol."},{"key":"B79","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0022-3565(25)10311-X","article-title":"A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin","volume":"263","author":"Godfraind","year":"","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B80","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1600-0773.1987.tb01779.x","article-title":"The actions of nifedipine and nisoldipine on the contractile activity of human coronary arteries and human cardiac tissue in vitro","volume":"61","author":"Godfraind","year":"1987","journal-title":"Pharmacol. Toxicol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1476-5381.1966.tb01877.x","article-title":"Specific antagonism to the direct and indirect action of angiotensin on the isolated guinea-pig ileum","volume":"28","author":"Godfraind","year":"1966","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"B82","first-page":"235","article-title":"Differences in sensitivity of arterial smooth muscles to inhibition of their contractile response to depolarization by potassium","volume":"172","author":"Godfraind","year":"1968","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"B83","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/01.RES.68.3.674","article-title":"Effects of a chronic treatment by nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats","volume":"68","author":"Godfraind","year":"1991","journal-title":"Circ. Res."},{"key":"B84","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0031-6997(25)06867-X","article-title":"Calcium antagonism and calcium entry blockade","volume":"38","author":"Godfraind","year":"","journal-title":"Pharmacol. Rev."},{"key":"B85","first-page":"29","article-title":"The heterogeneity of calcium movements in cardiac and vascular smooth muscle cells","volume":"180","author":"Godfraind","year":"","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"B86","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1097\/00005344-199206205-00006","article-title":"Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies","volume":"20","author":"Godfraind","year":"","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0008-6363(99)00306-5","article-title":"Voltage-gated calcium-channels and antiarrhythmic drug action","volume":"45","author":"Grace","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1161\/RES.0000000000000110","article-title":"Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the american heart association","volume":"119","author":"Griendling","year":"2016","journal-title":"Circ. Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"B90","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1073\/pnas.071582498","article-title":"Mechanisms of migraine aura revealed by functional MRI in human visual cortex","volume":"98","author":"Hadjikhani","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B91","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2165\/00023210-200317020-00002","article-title":"Pharmacological treatment of vertigo","volume":"17","author":"Hain","year":"2003","journal-title":"CNS Drugs"},{"key":"B92","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3171\/jns.1986.64.6.0951","article-title":"A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia","volume":"64","author":"Hall","year":"1986","journal-title":"J. Neurosurg."},{"key":"B93","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jns.2004.09.015","article-title":"Prevention of dementia: lessons from SYST-EUR and PROGRESS","volume":"226","author":"Hanon","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1046\/j.1440-1681.1999.03154.x","article-title":"Selective effects of lomerizine, a novel diphenylmethylpiperazine Ca2+ channel blocker, on cerebral blood flow in rats and dogs","volume":"26","author":"Hara","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/sj.bjp.0705281","article-title":"Dihydropyridine Ca(2+) channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4 K(+) channels expressed in HEK293 cells","volume":"139","author":"Hatano","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/01.RES.0000256155.31133.49","article-title":"Ca2+ channel subtypes and pharmacology in the kidney","volume":"100","author":"Hayashi","year":"2007","journal-title":"Circ. Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1006\/bbrc.1994.1883","article-title":"Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice","volume":"201","author":"Hayek","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1254\/jjp.85.339","article-title":"Molecular pharmacology of T-type Ca2+ channels","volume":"85","author":"Heady","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/jcp.1030290103","article-title":"The action of various cations on muscle protoplasm","volume":"29","author":"Heilbrunn","year":"1947","journal-title":"J. Cell. Comp. Physiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"3I","DOI":"10.1016\/0002-9149(90)91256-6","article-title":"Atherogenesis, calcium and calcium antagonists","volume":"66","author":"Henry","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0002-9343(89)90002-8","article-title":"Chronic stable angina monotherapy. Nifedipine versus propranolol","volume":"86","author":"Higginbotham","year":"1989","journal-title":"Am. J. Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1085\/jgp.69.4.497","article-title":"Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction","volume":"69","author":"Hille","year":"1977","journal-title":"J. Gen. Physiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.wneu.2015.11.081","article-title":"Long-term, continuous intra-arterial nimodipine treatment of severe vasospasm after aneurysmal subarachnoid hemorrhage","volume":"88","author":"Hockel","year":"2016","journal-title":"World Neurosurg."},{"key":"B104","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00005344-198405000-00005","article-title":"PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta","volume":"6","author":"Hof","year":"1984","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1042\/cs1010421","article-title":"Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis","volume":"101","author":"Honda","year":"2001","journal-title":"Clin. Sci."},{"key":"B106","first-page":"241","article-title":"Use of the calcium blocking agents in the treatment of classic exertional angina","volume-title":"Calcium Blocking Agents in the Treatment of Cardiovascular Disorders","author":"Hopf","year":"1983"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1253\/circj.CJ-16-0692","article-title":"Calcium-channel blockers and dementia risk in older adults- national health insurance service - senior cohort (2002-2013)","volume":"80","author":"Hwang","year":"2016","journal-title":"Circ. J."},{"key":"B108","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/hyp.0000000000000053","article-title":"Impact of hypertension on cognitive function: a scientific statement from the american heart association","volume":"68","author":"Iadecola","year":"2016","journal-title":"Hypertension"},{"key":"B109","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0014-2999(80)90365-9","article-title":"Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats","volume":"64","author":"Ishii","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"B110","first-page":"582","article-title":"The effectiveness of lidoflazine and other coronary vasodilatators after oral administration in the trained non-anesthethetized dog","volume":"17","author":"Jagenau","year":"1967","journal-title":"Arzneim Forsch"},{"key":"B111","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"B112","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s002100100468","article-title":"Preferential renal and mesenteric vasodilation induced by barnidipine and amlodipine in spontaneously hypertensive rats","volume":"364","author":"Janssen","year":"2001","journal-title":"Naunyn Schmiedebergs. Arch. Pharmacol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/0002-9149(81)90583-X","article-title":"Angina pectoris: effects of lidoflazine on exercise tolerance and chest pain","volume":"48","author":"Jenkins","year":"1981","journal-title":"Am. J. Cardiol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0002-9343(81)90180-7","article-title":"Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris","volume":"71","author":"Johnson","year":"1981","journal-title":"Am. J. Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/01.ATV.16.3.425","article-title":"Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group","volume":"16","author":"Jukema","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1055\/s-0028-1105006","article-title":"The effect of iproveratril on angina pectoris and the adrenergic beta-receptors of man","volume":"93","author":"Kaltenbach","year":"1968","journal-title":"Dtsch. Med. Wochenschr."},{"key":"B117","first-page":"469","article-title":"Disturbances initiated from naked surface of muscle protoplasm","volume":"10","author":"Kamada","year":"1943","journal-title":"Jpn. J. Zool."},{"key":"B118","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/0165-6147(89)90066-7","article-title":"Ca2+ localization and sensitivity in vascular smooth muscle","volume":"10","author":"Karaki","year":"1989","journal-title":"Trends Pharmacol. Sci."},{"key":"B119","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-3565(25)31794-5","article-title":"Alterations in high and low affinity binding of 45Ca in rabbit aortic smooth muscle by norepinephrine and potassium after exposure to lanthanum and low temperature","volume":"211","author":"Karaki","year":"1979","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B120","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1085\/jgp.98.1.63","article-title":"Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium","volume":"98","author":"Kass","year":"1991","journal-title":"J. Gen. Physiol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1161\/01.STR.0000014563.75483.22","article-title":"Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans","volume":"33","author":"Kasuya","year":"2002","journal-title":"Stroke"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1111\/j.1471-4159.1993.tb09803.x","article-title":"Coupling among energy failure, loss of ion homeostasis, and phospholipase A2 and C activation during ischemia","volume":"61","author":"Katsura","year":"1993","journal-title":"J. Neurochem."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1046\/j.1471-4159.2000.0752521.x","article-title":"Alterations in lipid and calcium metabolism associated with seizure activity in the postischemic brain","volume":"75","author":"Katsura","year":"2000","journal-title":"J. Neurochem."},{"key":"B124","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-3-642-74209-5_9","article-title":"Calcium antagonists","volume-title":"Pharmacology of Antihypertensive Therapeutics","author":"Kazda","year":"1990"},{"key":"B125","first-page":"316","article-title":"Differential influence of the calcium antagonist nitrendipine and the vasodilator hydralazine on normal and elevated blood pressure","volume":"269","author":"Knorr","year":"1984","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/01.HYP.37.4.1124","article-title":"Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats","volume":"37","author":"Krenek","year":"2001","journal-title":"Hypertension"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/sj.bjp.0704398","article-title":"Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats","volume":"134","author":"Kyselovic","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1124\/jpet.105.089847","article-title":"Calcium channel blocker inhibits Western-type diet-evoked atherosclerosis development in ApoE-deficient mice","volume":"315","author":"Kyselovic","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e006364","DOI":"10.1136\/bmjopen-2014-006364corr1","article-title":"Correction. NILVAD protocol: a European multicenter double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease","volume":"5","author":"Lawlor","year":"2015","journal-title":"BMJ Open"},{"key":"B130","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/302790a0","article-title":"Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells","volume":"302","author":"Lee","year":"1983","journal-title":"Nature"},{"key":"B131","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1161\/01.HYP.0000231662.77359.de","article-title":"Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial","volume":"48","author":"Leenen","year":"2006","journal-title":"Hypertension"},{"key":"B132","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3171\/jns.2002.97.2.0408","article-title":"Expression of members of the calcium-binding S-100 protein family in a rat model of cerebral basilar artery vasospasm","volume":"97","author":"Lefranc","year":"2002","journal-title":"J. Neurosurg."},{"key":"B133","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0002-9149(81)90582-8","article-title":"Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris","volume":"48","author":"Leon","year":"1981","journal-title":"Am. J. Cardiol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"S319","DOI":"10.1097\/00005344-198200433-00012","article-title":"Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects","volume":"4","author":"Leonetti","year":"1982","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1749-6632.1994.tb17315.x","article-title":"Cytokines regulate genes involved in atherogenesis","volume":"748","author":"Libby","year":"1995","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1097\/00005344-199500252-00003","article-title":"Cytokines regulate vascular functions related to stability of the atherosclerotic plaque","volume":"25","author":"Libby","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/0140-6736(90)91121-P","article-title":"Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators","volume":"335","author":"Lichtlen","year":"1990","journal-title":"Lancet"},{"key":"B138","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"J. Hypertens."},{"key":"B139","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/bmj.1.5850.375","article-title":"Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris","volume":"1","author":"Livesley","year":"1973","journal-title":"Br. Med. J."},{"key":"B140","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1526-4637.2011.01295.x","article-title":"A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis","volume":"13","author":"Luo","year":"2012","journal-title":"Pain Med."},{"key":"B141","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/bmj.281.6234.184","article-title":"Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination","volume":"281","author":"Lynch","year":"1980","journal-title":"Br. Med. J."},{"key":"B142","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1006\/jmcc.2002.2038","article-title":"Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond","volume":"34","author":"Maier","year":"2002","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jconrel.2015.12.044","article-title":"Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain","volume":"224","author":"Manda","year":"2016","journal-title":"J. Control. Release"},{"key":"B144","volume-title":"Drug Class Review on Calcium Channel Blockers","author":"McDonagh","year":"2005"},{"key":"B145","first-page":"761","article-title":"Iproveratril: experimental data on coronary dilatation and antiarrhythmic action","volume":"90","author":"Melville","year":"1964","journal-title":"Can. Med. Assoc. J."},{"key":"B146","volume-title":"Comparison of the Hemodynamic and Coronary Effects of Three Vasodilator Drugs: Dipyridamole, Nifedipine and Glyceryl Trinitrate","author":"Merillon","year":"1980"},{"key":"B147","doi-asserted-by":"publisher","first-page":"e011584","DOI":"10.1136\/bmjopen-2016-011584","article-title":"European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow","volume":"6","author":"Meulenbroek","year":"2016","journal-title":"BMJ Open"},{"key":"B148","first-page":"H1127","article-title":"Differential sensitivity to endothelin in canine arteries and veins","volume":"257","author":"Miller","year":"1989","journal-title":"Am. J. Physiol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"CD007938","DOI":"10.1002\/14651858.cd007938.pub3","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","volume":"16","author":"Moore","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0022-3565(25)11016-1","article-title":"Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle","volume":"243","author":"Morel","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B151","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/BF00167047","article-title":"Pharmacological properties of voltage-dependent calcium channels in functional microvessels isolated from rat brain","volume":"340","author":"Morel","year":"1989","journal-title":"Naunyn Schmiedebergs. Arch. Pharmacol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1476-5381.1991.tb12196.x","article-title":"Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine","volume":"102","author":"Morel","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/00005344-199410000-00002","article-title":"Selective interaction of the calcium antagonist amlodipine with calcium channels in arteries of spontaneously hypertensive rats","volume":"24","author":"Morel","year":"1994","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/sj.bjp.0702162","article-title":"The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunits","volume":"125","author":"Morel","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"B155","first-page":"159","article-title":"Neurovascular and molecular mechanisms in migraine headaches","volume":"5","author":"Moskowitz","year":"1993","journal-title":"Cerebrovasc. Brain Metab. Rev."},{"key":"B156","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","article-title":"The science of stroke: mechanisms in search of treatments","volume":"67","author":"Moskowitz","year":"2010","journal-title":"Neuron"},{"key":"B157","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1749-6632.1988.tb33397.x","article-title":"Control of cardiac arrhythmias by calcium antagonism","volume":"522","author":"Nademanee","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"B159","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-3565(25)27971-X","article-title":"Some effects of iproveratril (Isoptin) on the cardiovascular system","volume":"161","author":"Nayler","year":"1968","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B160","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1113\/jphysiol.1989.sp017604","article-title":"Dihydropyridine inhibition of single calcium channels and contraction in rabbit mesenteric artery depends on voltage","volume":"412","author":"Nelson","year":"1989","journal-title":"J. Physiol."},{"key":"B161","first-page":"H2","article-title":"Evidence for increased myofilament Ca2+ sensitivity in norepinephrine-activated vascular smooth muscle","volume":"259","author":"Nishimura","year":"1990","journal-title":"Am. J. Physiol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/SQB.1990.055.01.003","article-title":"Molecular insights into excitation-contraction coupling","volume":"55","author":"Numa","year":"1990","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1468-2982.1996.1605337.x","article-title":"Long-term follow-up after flunarizine or nimodipine discontinuation in migraine patients","volume":"16","author":"Nuti","year":"1996","journal-title":"Cephalalgia"},{"key":"B164","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0022-3565(24)39264-X","article-title":"Preferential inhibition by a novel Na(+)\/Ca(2+) channel blocker NS-7 of severe to mild hypoxic injury in rat cerebrocortical slices: A possible involvement of a highly voltage-dependent blockade of Ca(2+) channel","volume":"293","author":"Oka","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B165","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1046\/j.1471-4159.1999.0721315.x","article-title":"Blockade by NS-7, a neuroprotective compound, of both L-type and P\/Q-type Ca2+ channels involving depolarization-stimulated nitric oxide synthase activity in primary neuronal culture","volume":"72","author":"Oka","year":"1999","journal-title":"J. Neurochem."},{"key":"B166","first-page":"648","article-title":"Nitric oxide mechanisms in migraine","volume":"48","author":"Olesen","year":"2000","journal-title":"Pathol. Biol."},{"key":"B167","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4613-0863-8","volume-title":"Clinical Use of Calcium Channel Antagonist Drugs","author":"Opie","year":"1989"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0735-1097(00)00946-3","article-title":"First line drugs in chronic stable effort angina\u2013the case for newer, longer-acting calcium channel blocking agents","volume":"36","author":"Opie","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1161\/01.CIR.92.5.1068","article-title":"Nifedipine and mortality. Grave defects in the dossier","volume":"92","author":"Opie","year":"1995","journal-title":"Circulation"},{"key":"B170","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0735-1097(01)01728-4","article-title":"Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy","volume":"39","author":"Opie","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1053\/pcad.2000.7010","article-title":"Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies","volume":"43","author":"Opie","year":"2000","journal-title":"Prog. Cardiovasc. Dis."},{"key":"B172","doi-asserted-by":"publisher","first-page":"970741","DOI":"10.1155\/2014\/970741","article-title":"Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage","volume":"2014","author":"Ott","year":"2014","journal-title":"Biomed Res. Int."},{"key":"B173","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00005344-199902000-00010","article-title":"Renal afferent and efferent arteriolar dilation by nilvadipine: studies in the isolated perfused hydronephrotic kidney","volume":"33","author":"Ozawa","year":"1999","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1161\/cir.0000000000000311","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines and the heart rhythm society","volume":"67","author":"Page","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ceca.2006.04.029","article-title":"T-type calcium channels and tumor proliferation","volume":"40","author":"Panner","year":"2006","journal-title":"Cell Calcium"},{"key":"B176","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0304-3959(99)00254-7","article-title":"Adverse effects associated with the intrathecal administration of ziconotide","volume":"85","author":"Penn","year":"2000","journal-title":"Pain"},{"key":"B177","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/jpet.108.145672","article-title":"Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs","volume":"328","author":"Perez-Reyes","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B178","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0140-6736(10)60168-7","article-title":"Management of stable coronary artery disease","volume":"375","author":"Pfisterer","year":"2010","journal-title":"Lancet"},{"key":"B180","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00129492-200205000-00023","article-title":"New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study","volume":"23","author":"Pianese","year":"2002","journal-title":"Otol. Neurotol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-physiol-030212-183717","article-title":"Pathophysiology of migraine","volume":"75","author":"Pietrobon","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1161\/01.CIR.102.13.1503","article-title":"Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators","volume":"102","author":"Pitt","year":"2000","journal-title":"Circulation"},{"key":"B183","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"key":"B184","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial","volume":"364","author":"Poole-Wilson","year":"2004","journal-title":"Lancet"},{"key":"B185","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/ner.12274","article-title":"Intrathecal pharmacology update: novel dosing strategy for intrathecal monotherapy ziconotide on efficacy and sustainability","volume":"18","author":"Pope","year":"2015","journal-title":"Neuromodulation"},{"key":"B186","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ana.10159","article-title":"Nuclear factor-kappaB as a molecular target for migraine therapy","volume":"51","author":"Reuter","year":"2002","journal-title":"Ann. Neurol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0304-3959(99)00255-9","article-title":"Ziconotide for the treatment of severe spasticity after spinal cord injury","volume":"85","author":"Ridgeway","year":"2000","journal-title":"Pain"},{"key":"B188","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.yjmcc.2004.02.009","article-title":"Lidoflazine is a high affinity blocker of the HERG K(+)channel","volume":"36","author":"Ridley","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1113\/jphysiol.1883.sp000120","article-title":"A further contribution regarding the influence of the different constituents of the blood on the contraction of the heart","volume":"4","author":"Ringer","year":"1883","journal-title":"J. Physiol. (Lond)."},{"key":"B190","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2125.1980.tb01784.x","article-title":"Effects of nifedipine on resistance vessels, arteries and veins in man","volume":"10","author":"Robinson","year":"1980","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.0003-2409.2001.02399.x","article-title":"Gabapentin: pharmacology and its use in pain management","volume":"57","author":"Rose","year":"2002","journal-title":"Anaesthesia"},{"key":"B192","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1097\/00004872-199715110-00019","article-title":"Clinical results of the verapamil inhypertension and atherosclerosis study. VHAS investigators","volume":"15","author":"Rosei","year":"1997","journal-title":"J. Hypertens."},{"key":"B193","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1046\/j.1523-1755.62.s82.7.x","article-title":"Role of calcium channel blockers in the future, in view of the INSIGHT Study","volume":"82","author":"Rosenthal","year":"2002","journal-title":"Kidney Int. Suppl."},{"key":"B194","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/oxfordjournals.eurheartj.a060616","article-title":"Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction","volume":"15","author":"Rousseau","year":"1994","journal-title":"Eur. Heart J."},{"key":"B195","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1097\/HJH.0b013e3282ef7adc","article-title":"Crossover study of amlodipine versus nifedipine CR with home blood pressure monitoring via cellular phone: internet-mediated open-label crossover trial of calcium channel blockers for hypertension (i-TECHO trial)","volume":"25","author":"Ryuzaki","year":"2007","journal-title":"J. Hypertens."},{"key":"B196","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/01.CIR.66.3.574","article-title":"A double-blind randomized trial of propranolol and verapamil in the treatment of effort angina","volume":"66","author":"Sadick","year":"1982","journal-title":"Circulation"},{"key":"B197","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/BF00168443","article-title":"Facilitation of the vasorelaxant action of calcium antagonists by basal nitric oxide in depolarized artery","volume":"354","author":"Salomone","year":"1996","journal-title":"Naunyn Schmiedebergs. Arch. Pharmacol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/bmj.3.5612.224","article-title":"Clinical evaluation of verapamil in angina pectoris","volume":"3","author":"Sandler","year":"1968","journal-title":"Br. Med. J."},{"key":"B199","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1161\/01.RES.55.3.336","article-title":"Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists","volume":"55","author":"Sanguinetti","year":"1984","journal-title":"Circ. Res."},{"key":"B200","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1523\/JNEUROSCI.22-02-00396.2002","article-title":"Differential inhibition of T-type calcium channels by neuroleptics","volume":"22","author":"Santi","year":"2002","journal-title":"J. Neurosci."},{"key":"B201","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/sj.bjp.0702045","article-title":"Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists","volume":"125","author":"Sarsero","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"568","DOI":"10.5551\/jat.1628","article-title":"Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy","volume":"16","author":"Sasaki","year":"2009","journal-title":"J. Atheroscler. Thromb."},{"key":"B203","first-page":"1338","article-title":"Pharmacological studies on a new l,5-benzothiazepine derivative (CRD-401)","volume":"21","author":"Sato","year":"1971","journal-title":"Arzneimittelforschung"},{"key":"B204","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/cvr\/5.4.419","article-title":"Immediate effects of intravenous verapamil on atrial fibrillation","volume":"5","author":"Schamroth","year":"1971","journal-title":"Cardiovasc. Res."},{"key":"B205","first-page":"347","article-title":"Calcium channel blocking agents in tghe treatment of cardiac arrhythmias","volume-title":"Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders","author":"Schamroth","year":"1983"},{"key":"B206","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-3565(25)27319-0","article-title":"The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator","volume":"152","author":"Schaper","year":"1966","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B207","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-0773.1985.tb03575.x","article-title":"Diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study","volume":"57","author":"Schroeder","year":"1985","journal-title":"Acta Pharmacol. Toxicol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial\u2013Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"B209","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S0002-9149(83)80119-2","article-title":"Nifedipine in chronic stable angina: a double-blind placebo-controlled crossover trial","volume":"51","author":"Sherman","year":"1983","journal-title":"Am. J. Cardiol."},{"key":"B210","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1749-6632.1988.tb33410.x","article-title":"Historical overview. Calcium, ischemia, and death of brain cells","volume":"522","author":"Siesjo","year":"","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B211","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1097\/00003246-198810000-00006","article-title":"Mechanisms of ischemic brain damage","volume":"16","author":"Siesjo","year":"","journal-title":"Crit. Care Med."},{"key":"B212","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1161\/01.CIR.103.24.2949","article-title":"Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes","volume":"103","author":"Simon","year":"2001","journal-title":"Circulation"},{"key":"B213","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0008-6363(99)00305-3","article-title":"A fourth class of anti-dysrhythmic action? Effect of verapamil and ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function","volume":"45","author":"Singh","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"B214","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1748-1716.1987.tb08157.x","article-title":"Comparative effects of some calcium-channel blockers on human peripheral arteries and veins","volume":"130","author":"Sjoberg","year":"1987","journal-title":"Acta Physiol. Scand."},{"key":"B215","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/bmj.3.5775.632","article-title":"William Murrell, physician and practical therapist","volume":"3","author":"Smith","year":"1971","journal-title":"Br. Med. J."},{"key":"B216","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0304-3959(01)00436-5","article-title":"The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices","volume":"96","author":"Smith","year":"2002","journal-title":"Pain"},{"key":"B217","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1471-4892(01)00012-1","article-title":"Voltage-dependent calcium channels\u2013beyond dihydropyridine antagonists","volume":"1","author":"Snutch","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"key":"B218","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0031-6997(25)00463-6","article-title":"Classification of calcium channels and the sites of action of drugs modifying channel function","volume":"44","author":"Spedding","year":"1992","journal-title":"Pharmacol. Rev."},{"key":"B219","first-page":"5","article-title":"Factors modifying the tissue selectivity of calcium-antagonists","volume":"31","author":"Spedding","year":"1990","journal-title":"J. Neural Transm. Suppl."},{"key":"B220","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1161\/01.HYP.0000145864.95630.20","article-title":"Cognitive impairment and blood pressure: quo usque tandem abutere patientia nostra?","volume":"44","author":"Staessen","year":"2004","journal-title":"Hypertension"},{"key":"B221","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) trial investigators","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"B222","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1152\/ajplegacy.1901.5.6.338","article-title":"On the rhythmic activity of the oesophagus and the influence upon it of varfious media","volume":"5","author":"Stiles","year":"1901","journal-title":"Am. J. Physiol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1358\/dot.2008.44.5.1186403","article-title":"Gabapentin: a Ca2+ channel alpha 2-delta ligand far beyond epilepsy therapy","volume":"44","author":"Striano","year":"2008","journal-title":"Drugs Today"},{"key":"B224","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/S0140-6736(00)04440-8","article-title":"Targeting voltage-gated Ca2+ channels","volume":"357","author":"Striessnig","year":"2001","journal-title":"Lancet"},{"key":"B225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0022-3565(25)10629-0","article-title":"Calcium channel antagonists: cardiovascular selectivity of action","volume":"274","author":"Sun","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B226","doi-asserted-by":"crossref","DOI":"10.1201\/9780203909966","volume-title":"Analytical Techniques in Combinatorial Chemistry","author":"Swartz","year":"2000"},{"key":"B227","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0002-9149(82)90520-3","article-title":"Verapamil in stable effort angina: effects on left ventricular function evaluated with exercise radionuclide ventriculography","volume":"49","author":"Tan","year":"1982","journal-title":"Am. J. Cardiol."},{"key":"B228","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature19102","article-title":"Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs","volume":"537","author":"Tang","year":"2016","journal-title":"Nature"},{"key":"B229","volume-title":"Effects of Nitrendipine on Organ Vasculature and Baroreceptor Reflexes","author":"Taylor","year":"1984"},{"key":"B230","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0028-3908(98)00233-0","article-title":"Drug-induced parkinsonism: cinnarizine and flunarizine are potent uncouplers of the vacuolar H+-ATPase in catecholamine storage vesicles","volume":"38","author":"Terland","year":"1999","journal-title":"Neuropharmacology"},{"key":"B231","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0002-8703(82)90256-3","article-title":"Nifedipine therapy in angina pectoris: evaluation of safety and side effects","volume":"104","author":"Terry","year":"1982","journal-title":"Am. Heart J."},{"key":"B232","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/1074248414555403","article-title":"Calcium channel blockers and hypertension","volume":"20","author":"Tocci","year":"2015","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"B233","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1124\/pr.55.2.3","article-title":"The pharmacology of nitric oxide in the peripheral nervous system of blood vessels","volume":"55","author":"Toda","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"B234","doi-asserted-by":"publisher","first-page":"13284","DOI":"10.1073\/pnas.192242399","article-title":"Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons","volume":"99","author":"Tottene","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B235","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0014-2999(99)00329-5","article-title":"The pharmacology of ion channels: with particular reference to voltage-gated Ca2+ channels","volume":"375","author":"Triggle","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"B237","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/sj.bjp.0701342","article-title":"Blockade of N-type Ca2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones","volume":"122","author":"Uneyama","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"B238","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/01.RES.30.1.44","article-title":"Excitation-contraction coupling in rabbit aorta studied by the lanthanum method for measuring cellular calcium influx","volume":"30","author":"Van Breemen","year":"1972","journal-title":"Circ. Res."},{"key":"B239","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0304-3959(99)00241-9","article-title":"Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia","volume":"85","author":"Vanegas","year":"2000","journal-title":"Pain"},{"key":"B240","first-page":"1","article-title":"Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)","volume":"22","author":"Vater","year":"1972","journal-title":"Arzneimittelforschung"},{"key":"B241","volume-title":"Cardiac Output and Regional Blood Flow","author":"Wade","year":"1962"},{"key":"B242","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1212\/WNL.64.10_suppl_2.S9","article-title":"Migraine as an inflammatory disorder","volume":"64","author":"Waeber","year":"2005","journal-title":"Neurology"},{"key":"B243","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/HYPERTENSIONAHA.107.089763","article-title":"Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers. A quantitative overview","volume":"50","author":"Wang","year":"2007","journal-title":"Hypertension"},{"key":"B244","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0304-3959(99)00214-6","article-title":"Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats","volume":"84","author":"Wang","year":"2000","journal-title":"Pain"},{"key":"B245","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3565(25)28347-1","article-title":"Effects of lanthanum on contraction, calcium distribution and Ca45 movements in intestinal smooth muscle","volume":"169","author":"Weiss","year":"1969","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B246","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1201\/9780203909966.ch1","article-title":"An introduction to combinatorial chemistry","volume-title":"Analytical Techniques in Combinatorial Chemistry","author":"Weller","year":"2000"},{"key":"B247","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1161\/01.RES.73.5.974","article-title":"Subunit-dependent modulation of recombinant L-type calcium channels. Molecular basis for dihydropyridine tissue selectivity","volume":"73","author":"Welling","year":"1993","journal-title":"Circ. Res."},{"key":"B248","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/01.RES.81.4.526","article-title":"Alternatively spliced IS6 segments of the alpha 1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels","volume":"81","author":"Welling","year":"1997","journal-title":"Circ. Res."},{"key":"B249","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/01.RES.68.3.662","article-title":"Postnatal maturation of excitation-contraction coupling in rat ventricle in relation to the subcellular localization and surface density of 1,4-dihydropyridine and ryanodine receptors","volume":"68","author":"Wibo","year":"1991","journal-title":"Circ. Res."},{"key":"B250","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/01.RES.62.1.91","article-title":"Pharmacologic relevance of dihydropyridine binding sites in membranes from rat aorta: kinetic and equilibrium studies","volume":"62","author":"Wibo","year":"1988","journal-title":"Circ. Res."},{"key":"B251","doi-asserted-by":"publisher","first-page":"e4593","DOI":"10.1097\/MD.0000000000004593","article-title":"A 10-year follow-up study of the association between calcium channel blocker use and the risk of dementia in elderly hypertensive patients","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine"},{"key":"B252","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/sj.bjp.0704753","article-title":"Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism","volume":"136","author":"Xu","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"B253","first-page":"H140","article-title":"Effects of dihydropyridine calcium channel modulators on cardiac sodium channels","volume":"254","author":"Yatani","year":"1988","journal-title":"Am. J. Physiol."},{"key":"B254","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/01.RES.60.4.523","article-title":"Whole-cell and single-channel calcium currents of isolated smooth muscle cells from saphenous vein","volume":"60","author":"Yatani","year":"1987","journal-title":"Circ. Res."},{"key":"B255","first-page":"69","article-title":"The role of the kidney in neurohormonal cardiovascular regulation","volume":"571","author":"Zanchetti","year":"1988","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"B256","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1161\/01.CIR.0000039288.86470.DD","article-title":"Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial","volume":"106","author":"Zanchetti","year":"2002","journal-title":"Circulation"},{"key":"B257","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1097\/00004872-199816110-00014","article-title":"The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness","volume":"16","author":"Zanchetti","year":"1998","journal-title":"J. Hypertens."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00286\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T16:45:24Z","timestamp":1750265124000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00286\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,29]]},"references-count":257,"alternative-id":["10.3389\/fphar.2017.00286"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00286","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,29]]},"article-number":"286"}}